Key Takeaway: Bioavailability is the single most important factor in supplementation
1 Month Over several weeks, blood pressure and blood sugar may begin to stabilize, often leading to clearer thinking and better energy. 3 Months With consistent use, SGLT2 Inhibitors may mimic steady calorie restriction, activating longevity pathways that may clear senescent cells and reduce inflammation. 6 Months By 6 months, Invokana may encourage moderate weight loss of 2-4% body weight, potentially improving VO2 max with measurable reductions in diabetes and heart disease risk. 1 Year+ The true benefits of SGLT2 Inhibitors emerge, potentially offering increased protection against heart disease, kidney disease, dementia, and overall mortality. Given the ample preclinical and clinical evidence, SGLT2 inhibitors remain at the top of the list of potential gerotherapeutic drugs Michael Leone & Nir Barzilai, An Updated Prioritization of Geroscience Why AgelessRx
Can a genetic test help me choose between GLP-1 providers or formulations
Efficacy of exenatide administered twice daily in body mass index reduction in patients with type 2 diabetes mellitus
When you stop taking either drug, your blood sugar may rise and you may gain weight
